Veröffentlichungen

Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma

B. Edginton-White
P. Cauchy
S.A. Assi
S. Hartmann
A.G. Riggs
S. Mathas
P.N. Cockerill
C. Bonifer

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

L. von Hoff
E. Kärgel
V. Franke
E. McShane
K.W. Schulz-Beiss
G. Patone
N. Schleussner
M. Kolesnichenko
N. Hübner
O. Daumke
M. Selbach
A. Akalin
S. Mathas
C. Scheidereit

01. September 2018 in Leukemia

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

N. Schleussner
O. Merkel
M. Costanza
H.C. Liang
F. Hummel
C. Romagnani
P. Durek
I. Anagnostopoulos
M. Hummel
K. Jöhrens
A. Niedobitek
P.R. Griffin
R. Piva
H.L. Sczakiel
W. Woessmann
C. Damm-Welk
C. Hinze
D. Stoiber
B. Gillissen
S.D. Turner
E. Kaergel
L. von Hoff
M. Grau
G. Lenz
B. Dörken
C. Scheidereit
L. Kenner
M. Janz
S. Mathas

Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas

S. Mathas
K. Joehrens
S. Joos
A. Lietz
F. Hummel
M. Janz
F. Jundt
I. Anagnostopoulos
K. Bommert
P. Lichter
H. Stein
C. Scheidereit
B. Doerken

A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas

F. Jundt
N. Raetzel
C. Mueller
C.F. Calkhoven
K. Kley
S. Mathas
A. Lietz
A. Leutz
B. Doerken